id: methadone_continuation_during_incarceration_to_fatal_overdose_post_release
name: Methadone Treatment Continuation During Incarceration â†’ Fatal Overdose Post-Release
from_node:
  node_id: methadone_continuation_during_incarceration
  node_name: Methadone Treatment Continuation During Incarceration
to_node:
  node_id: fatal_overdose_post_release
  node_name: Fatal Overdose Post-Release
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Methadone continuation during incarceration prevents tolerance loss that
  occurs with forced abstinence during detention'
- 'Step 2: Maintained tolerance reduces vulnerability to overdose from lower doses
  of illicit opioids upon release'
- 'Step 3: Treatment continuation facilitates smoother transition to community treatment,
  reducing the high-risk period of treatment gap'
- 'Step 4: Sustained medication management during incarceration provides protective
  physiological effects immediately post-release when overdose risk is highest'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Alissa Haas et al. 2021. "Post-incarceration outcomes for individuals
    who continued methadone treatment while in Connecticut jails, 2014-2018.." *Drug
    and alcohol dependence*. https://doi.org/10.1016/j.drugalcdep.2021.108937
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.410743'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
